FDA Announces Joint Meeting of Pediatric and Oncologic Drugs Advisory Committees

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of its Pediatric Advisory Committee and Oncologic Drugs Advisory Committee to discuss new cancer treatments and pediatric medications.